BackCyclo Therapeutics- Warrants (14/11/2025) Overview

Cyclo Therapeutics- Warrants (14/11/2025) Inventory

Latest inventory for CYTHW: $240K.

Get informed when a big investor buys or sells

+ Follow
Inventory
$236110.00
12.56% YoYΔ $26355.00 vs prior year quarter

Peer trimmed avg / median

Loading

Cyclo Therapeutics- Warrants (14/11/2025) Inventory History

Loading

Cyclo Therapeutics- Warrants (14/11/2025) vs. peers: Inventory Comparison

Loading

Cyclo Therapeutics- Warrants (14/11/2025) Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Cyclo Therapeutics- Warrants (14/11/2025) (CYTHW) FAQ

As of the most recent data (September 2024), CYTHW shows a inventory of $240K. That compares with $210K in the prior-year period — up 12.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CYTHW's inventory is now $240K (was $210K) — a 12.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Cyclo Therapeutics- Warrants (14/11/2025) is outperforming or lagging.

Tracking CYTHW's inventory over time shows whether Cyclo Therapeutics- Warrants (14/11/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $240K That compares with $210K in the prior-year period — up 12.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Cyclo Therapeutics- Warrants (14/11/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $240K) with ownership activity and broader fundamentals.

Cyclo Therapeutics- Warrants (14/11/2025)'s inventory is $240K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.